A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-6345 in Healthy Subjects
Clinical trial NCT03809039 · TERMINATED
Trial details
- NCT number
- NCT03809039
- Sponsor
- Tanabe Pharma America, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-15
- Primary completion
- 2019-07-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.